Mark McCamish

Active Investor

President and CEO at IconOVir Bio

San Diego, California

Mark McCamish, President and CEO at IconOVir Bio is an active investor based in San Diego, California. This profile covers what Mark McCamish backs, at which stage, and how founders can reach out in 2026.

Dr. Mark McCamish serves as President & Chief Executive Officer at IconOVir Bio. He serves as Board Member at Shasqi. Dr. Mark serves as Board Member at Avadel Pharmaceuticals. He served as President, Chief Executive Officer & Board Member at Forty-Seven. He served as a Board Member at Vincerx Pharma. He is also an angel investor. From July 2009 to April 2017, Mark served as Global Head of Biopharmaceutical Development at Sandoz Inc., a pharmaceutical company. He has over 25 years of experience in corporate management, clinical and pharmaceutical research, and academics. Mark received both a BA in physical education and an MA in ergonomics from the University of California at Santa Barbara, a PhD in nutritional sciences from Pennsylvania State University, and an MD from the University of California at Los Angeles.

Investor type: Angel
Stages: Pre SeedSeed
Invests in: Healthcare & BiotechBiotech & PharmaIoT & Connected Devices
Location: San Diego, California
Typical check: $150K
Past investments: 2

Notable investments

AbbottNemesis Bioscience

How to reach Mark McCamish

Angels and operators like Mark McCamish reply to specific, personalized notes that show real traction, not mass blasts. Build a verified list, write a note that fits their thesis, and track replies, all on Round Funded.

Frequently Asked Questions

What does Mark McCamish invest in?

Mark McCamish invests in Healthcare & Biotech, Biotech & Pharma and IoT & Connected Devices, typically at Pre Seed and Seed. Match your sector and stage, then reach out with a personalized pitch.